LATEST
Tue, Oct 6, 2026
Loading weather...
Markets

Galderma Highlights Recent Restylane Approvals At 30-Year Mark

(RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reache...

(RTTNews) - Galderma Group AG (GALD.SW, GDERF) announced that its Restylane injectable aesthetic product line has reached its 30th anniversary since its European launch. Restylane, which was introduced as a hyaluronic acid injectable, has since expanded into a portfolio of produc

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

GRAIL To Highlight NHS-Galleri, PATHFINDER 2 Findings Amid FDA Review; Stock Up

(RTTNews) - GRAIL, Inc. (GRAL), a healthcare company, will present additional da...

Read Article »

Cuba mantiene luces encendidas con energía solar de EE.UU.

Cuando Cuba sufrió su séptimo apagón nacional del año, la fiesta siguió en La Ca...

Read Article »

Best auto stocks to buy ahead of Q2 results: Eicher, Hyundai Motor, Tata Motors PV among Nuvama’s top picks | Full list

Nuvama Institutional Equities maintains a positive outlook on the auto sector, w...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.